State Street’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.08M Sell
2,722,742
-67,035
-2% -$75.8K ﹤0.01% 3152
2025
Q1
$4.07M Sell
2,789,777
-4,460,189
-62% -$6.51M ﹤0.01% 2960
2024
Q4
$15.4M Buy
7,249,966
+236,883
+3% +$505K ﹤0.01% 2367
2024
Q3
$19.6M Sell
7,013,083
-655,041
-9% -$1.83M ﹤0.01% 2213
2024
Q2
$17.9M Sell
7,668,124
-1,515,887
-17% -$3.53M ﹤0.01% 2220
2024
Q1
$41.1M Buy
9,184,011
+6,756,727
+278% +$30.2M ﹤0.01% 1823
2023
Q4
$7.79M Sell
2,427,284
-5,775,317
-70% -$18.5M ﹤0.01% 2724
2023
Q3
$26M Sell
8,202,601
-276,160
-3% -$875K ﹤0.01% 2015
2023
Q2
$42.1M Buy
8,478,761
+267,687
+3% +$1.33M ﹤0.01% 1775
2023
Q1
$40.6M Sell
8,211,074
-955,334
-10% -$4.72M ﹤0.01% 1792
2022
Q4
$57.7M Buy
9,166,408
+2,486,111
+37% +$15.6M ﹤0.01% 1527
2022
Q3
$72.1M Buy
6,680,297
+1,025,973
+18% +$11.1M ﹤0.01% 1333
2022
Q2
$64.5M Sell
5,654,324
-2,223,324
-28% -$25.3M ﹤0.01% 1459
2022
Q1
$71.8M Buy
7,877,648
+3,464,603
+79% +$31.6M ﹤0.01% 1523
2021
Q4
$65.8M Buy
4,413,045
+899,729
+26% +$13.4M ﹤0.01% 1614
2021
Q3
$90.3M Buy
3,513,316
+508,416
+17% +$13.1M ﹤0.01% 1345
2021
Q2
$78.4M Buy
3,004,900
+671,104
+29% +$17.5M ﹤0.01% 1498
2021
Q1
$82.4M Sell
2,333,796
-1,039,665
-31% -$36.7M ﹤0.01% 1380
2020
Q4
$85.1M Buy
3,373,461
+809,829
+32% +$20.4M 0.01% 1268
2020
Q3
$96.7M Buy
2,563,632
+305,841
+14% +$11.5M 0.01% 992
2020
Q2
$96.7M Buy
2,257,791
+563,575
+33% +$24.1M 0.01% 986
2020
Q1
$32.9M Buy
1,694,216
+14,766
+0.9% +$287K ﹤0.01% 1522
2019
Q4
$43.6M Buy
1,679,450
+335,655
+25% +$8.72M ﹤0.01% 1606
2019
Q3
$36.6M Sell
1,343,795
-259,426
-16% -$7.07M ﹤0.01% 1661
2019
Q2
$43M Buy
1,603,221
+477,362
+42% +$12.8M ﹤0.01% 1578
2019
Q1
$32.5M Buy
1,125,859
+771,067
+217% +$22.3M ﹤0.01% 1727
2018
Q4
$9.56M Buy
+354,792
New +$9.56M ﹤0.01% 2461